Skip to search formSkip to main contentSkip to account menu

proadrenomedullin (9-20)

Known as: PAMP(9-20), PAMP-12 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Objective(s): The study aimed to investigate the effects of adrenomedullin (ADM) and proadrenomedullin N- terminal 20 peptide… 
2009
2009
OBJECTIVE There are evidences that proadrenomedullin N-terminal 20 peptide (PAMP) and calcitonin may be involved in… 
2003
2003
In this study, we observed the levels of adrenomedullin (ADM) and proadrenomedullin N-terminal 20 peptide (PAMP) in myocardium… 
2002
2002
OBJECTIVE To study the changes in plasma adrenomedullin (ADM) and proadrenomedullin N-terminal 20 peptide (PAMP) concentrations… 
1999
1999
We examined the effects of proadrenomedullin-derived peptides on the release of adrenal catecholamines in response to cholinergic… 
1999
1999
The novel hypotensive peptide, proadrenomedullin N-terminal 20 peptide (PAMP), is processed from the adrenomedullin precursor… 
1998
1998
Proadrenomedullin N-terminal 20 peptide (PAMP) is a novel bloactive peptide found in the N-terminal portion of adrenomedullin…